Pfizer Stock Price Increased

Pfizer (NYSE: PFE), once celebrated for its COVID vaccine, is experiencing a stock increase of 2.1% after announcing plans to acquire another drug company in an effort to rebound from the setback of its weight loss drug, danuglipron. This move aims to capitalize on the growing market for weight loss treatments amid the Ozempic trend.

Want More Context? 🔎